CES Antibodies

Santa Cruz Biotechnology delivers a wide array of CES Antibodies for targeting carboxylesterases, a family of enzymes that play a crucial role in the metabolism of various endogenous and exogenous compounds. CES Antibodies are compatible with multiple research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Carboxylesterases are involved in the hydrolysis of ester bonds, contributing to the detoxification of drugs and environmental toxins, as well as the metabolism of lipids and other biomolecules. The activity of carboxylesterases is essential for maintaining homeostasis and can influence drug efficacy and toxicity, making them significant in pharmacology and toxicology studies. CES Antibodies enable researchers to explore the diverse roles of carboxylesterases in cellular processes and disease mechanisms. Investigating carboxylesterase function through molecular and cellular studies can reveal new therapeutic targets and enhance drug development strategies. Understanding carboxylesterase regulation and activity patterns may provide valuable insights into metabolic disorders and drug resistance mechanisms. Santa Cruz Biotechnology monoclonal antibodies for CES research support scientists in advancing knowledge of enzyme function and developing innovative therapeutic approaches.